Arginase release following liver reperfusion: Evidence of hemodynamic action of arginase infusions

Transplantation

Volumn 59, Issue 11, 1995, Pages 1542-1549

  Längle, Friedrich ^a   Roth, Erich ^a   Steininger, Rudolf ^a   Winkler, Susanne ^a   Mühlbacher, Ferdinand ^a  

^a UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ARGINASE;

ANIMAL EXPERIMENT; ARTICLE; ENZYME BLOOD LEVEL; ENZYME RELEASE; GRAFT REJECTION; LIVER BLOOD FLOW; LIVER PERFUSION; LIVER TRANSPLANTATION; NONHUMAN; OXIDATION REDUCTION REACTION; PATHOGENESIS; PRIORITY JOURNAL; PULMONARY HYPERTENSION; REPERFUSION INJURY; SWINE;

ANIMAL; ARGINASE; COMPARATIVE STUDY; FEMALE; HEMODYNAMICS; INFUSIONS, INTRAVENOUS; LIVER; LIVER TRANSPLANTATION; MALE; REPERFUSION INJURY; SWINE;

EID: 0029021858     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199506000-00007     Document Type: Article

References (41)

1. Zadrobilek E, Mauritz EW, Feil W, Wenzl E, Sporn P. Hemody namic and metabolic changes during orthotopic liver trans plantation. Anaesthesist 1988; 37: 672.
2. Paulsen AW, Valek TR, Blessing WS, et al. Hemodynamics dur ing liver transplantation with veno-venous bypass. Transplan Proc 1987; 19: 2417.
3. Ringe B, Bornscheuer A, Blumhardt G, Bechstein WO, Wonigei K, Pichlmayr R. Experience with veno-venous bypass in hu man liver transplantation. Transplant Proc 1987; 19: 2416.
4. Gabriel A, Müller C, Tíichy G, Hackl W, Zimpfer M. Reperfusior during orthotopic liver transplantation: analysis of right ven tricular dynamics. Transplant Proc 1993; 25: 1811.
5. Delva E, Barberousse JP, Nordlinger B, et al. Hemodynamic and biochemical monitoring during major liver resection with use of hepatic vascular exclusion. Surgery 1984; 95: 309.
6. Ofľenstadt G, Huguet C, Gallot D, Bloch P. Hemodynamic mon itoring during complete vascular exclusion for extensive hep atectomy. Surg Gynecol Obstet 1978; 146: 713.
7. Harvey RM, Enson Y, Ferrer MI. A reconsideration of the originins of pulmonary hypertension. Chest 1971; 59: 82.
8. Roth E, Steininger R, Winkler S. L-Arginine deficiency after liver transplantation as an effect of arginase efflux from the graft. Influence of nitric oxide metabolism. Transplantation 1994; 57: 665.
9. Moncada S, Palmer RMJ, Higgs EA. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 1991; 43: 109.
10. Änggard E. Nitric oxide: mediator, murderer, and medicine. Lancet 1994; 343: 1199.
11. Nakaki T, Hishikawa K, Suzuki H, Saruta T, Kato R. L-Arginine-induced hypotension. Lancet 1990; 336: 696.
12. Ikemoto M, Ishida A, Tsunekawa S, et al. Enzyme immunoassay of liver-type arginase and its potential clinical application. Clin Chem 1993; 39: 794.
13. Straus B, Cepelak I, Festa G. Arginase, a new marker of mam mary carcinoma. Clin Chim Acta 1992; 210: 5.
14. Wu CW, Wang SR, Chien SL, et al. Regulation of arginase production by glucocorticoid in three human gastric cancer cell lines. Life Sci 1992; 51: 1355.
15. Leu SY, Wang SR. Clinical significance of arginase in colorectal cancer. Cancer 1992; 70: 733.
16. Pelikan V, Kalab M, Tichy J. Determination of arginase activity in blood in epidemic hepatitis. Clin Chim Acta 1964; 9: 141.
17. Coles EH. Liver function. In: Veterinary clinical pathology, 4th ed. Philadelphia: WB Saunders, 1986.
18. Turnell DC, Cooper JDH. Rapid assay for amino acids in serum or urine by pre-column derivatization and reverse-phase liquid chromatography. Clin Chem 1991; 28: 527.
19. Kaneda N, Sato M, Yagi K. Analysis of dansyl amino acids by reverse-phase liquid chromatography. Anal Biochem 1982; 127: 49.
20. Bastone A, Diomede L, Parini R, Carnevale F, Salmoma M. Determination of argininosuccinate lyase and arginase activities with an amino analyzer. Anal Biochem 1990; 191: 384.
21. Green LC, Wagner DA, Glogowski J, Skipper PL, Wishnok Tannenbaum SR. Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids. Anal Biochem 1982; 126: 131.
22. Pastor C, Teisseire B, Vicaut E, Payen D. Effects of L-arginine and L-nitro-arginine treatment on blood pressure and cardiac output in a rabbit endotoxin shock model. Crit Care Med 1994; 22: 465.
23. Lorente JA, Landin L, de Pablo R, Renes E, Liste D. L-Arginine pathway in the sepsis syndrome. Crit Care Med 1993; 21: 1287
24. Heinzel B, John M, Klatt P, B hme E, Mayer B. Ca2+/calmodulin-dependent formation of hydrogen peroxide by brain nitric oxide synthase. Biochem J 1992; 281: 627.
25. Hecker M, Sessa WC, Harris HJ, Anggard EE, Vane JR. The metabolism of L-arginine and its significance for the biosynthesis of endothelium-derived relaxing factor: cultured endothelial cells recycle L-citrulline to L-arginine. Proc Natl Acad Sci USA 1990; 87: 8612.
26. Kilbourn RG, Belloni P. Endothelial cell production of nitrogen oxides in response to interferon-gamma in combination with tumor necrosis factor, interleukin-1, or endotoxin. J Natl Cancer Inst 1990; 82: 772.
27. Inoue Y, Bode BP, Beck DJ, Li AP, Bland KI, Souba WW. Arginine transport in human liver. Characterization and efι fects of nitric oxide synthase inhibitors. Ann Surg 1993; 218: 350.
28. Greene B, Pacitti AJ, Souba WW. Characterization of L-arginine 1 transport by pulmonary artery endothelial cells. Am J Physiol 1993; 264: L351.
29. McCord JM. Oxygen-derived free radicals in postischemic tissue injury. N Engl J Med 1985; 312: 159.
30. Paterson IS, Klausner JM, Pugatsch R, et al. Noncardiogenic pulmonary edema after abdominal aortic aneurysm surgery. i Ann Surg 1989; 209: 231.
31. Lucchesi BR. Modulation of leukocyte-mediated myocardial reperfusion injury. Annu Rev Physiol 1990; 52: 561.
32. Palombo JD, Blackburn GL, Forse RA. Endothelial cell factors and response to injury. Surg Gynecol Obstet 1991; 173: 505.
33. Griffith OW, Parks KH, Aisaka K, Levi R, Gross SS. The role of plasma arginine in nitric oxide synthesis: studies with arginase-treated guinea pigs and rats. In: Moncada S, Marietta MA, Higgs JB Jr, Higgs EA, eds. The biology of nitric oxide. London and Chapel Hill: Portland Press, 1992: 6.
34. Spain DA, Wilson MA, Garrison RN. Nitric oxide: a compensatory mediator of bacteremia-induced visceral microvasculai hypoperfusion. Intensive Care Med 1994; 20: S48.
35. Pepke-Zaba J, Higenbottam TW, Tuan Dinh-Xuan A, Stone D, Wallwork J. Inhaled nitric oxide as a cause of selective pulmonary vasodilatation in pulmonary hypertension. Lancet 1991 338: 1173.
36. Hrabak A, Temesi A, Csuka I, Antoni F. Inverse relation in the de novo arginase synthesis and nitric oxide production in murine and rat peritoneal macrophages in long-term cultures in vitro. Comp Biochem Physiol 1992; 103B: 839.
37. Jansen A, Lewis S, Cattell V, Cook HT. Arginase is a major pathway of L-arginine metabolism in nephritic glomeruli. Kidney Int 1992; 42: 1107.
38. Pinsky DJ, Oz MC, Koga S. Cardiac preservation is enhanced in a heterotopic rat transplant model by supplementing the nitric oxide pathway. J Clin Invest 93: 2291.
39. Mittal M, Gupta T, Lee FY, Sieber C, Groszmann RJ. Nitric oxide modulates hepatic vascular tone in normal rat liver. Am J Physiol 1994; 267: G416.
40. Jaeschke H, Schini VB, Farhood A. Role of nitric oxide in the oxidant stress during ischemia/reperfusion injury of the liver. Life Sci 1992; 50: 1797.
41. Minor T, Yamaguchi T, Isselhard W. Amelioration of postischemic reflow and cellular integrity in the rat liver by L-arginine. Workshop:Experimental Liver Transplantation, 1993, Frankfurt, Germany.